Norway Savings Bank Amgen Inc Transaction History

Norway Savings Bank

$184 Million
Q3 2024

A detailed history of Norway Savings Bank transactions in Amgen Inc stock. As of the latest transaction made, Norway Savings Bank holds 3,806 shares of AMGN stock, worth $1.1 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

3,806

Previous 3,377 12.7%

Holding current value

$1.1 Million

Previous $1.06 Million 16.21%

% of portfolio

0.67%

Previous 0.6%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$309.38 - $337.38 $132,724 - $144,736	429 Added 12.7%	3,806 $1.23 Million
Q2 2024 Jul 12, 2024	BUY	$262.75 - $319.31 $69,891 - $84,936	266 Added 8.55%	3,377 $1.06 Million
Q1 2024 Apr 16, 2024	BUY	$268.87 - $324.56 $172,076 - $207,718	640 Added 25.9%	3,111 $884,000
Q4 2023 Jan 12, 2024	BUY	$255.7 - $288.46 $54,975 - $62,018	215 Added 9.53%	2,471 $711,000
Q3 2023 Oct 23, 2023	BUY	$218.65 - $271.46 $5,684 - $7,057	26 Added 1.17%	2,256 $606,000
Q2 2023 Jul 11, 2023	BUY	$214.27 - $253.37 $131,776 - $155,822	615 Added 38.08%	2,230 $495,000
Q1 2023 Apr 11, 2023	BUY	$225.79 - $275.2 $313,848 - $382,528	1,390 Added 617.78%	1,615 $390,000
Q2 2022 Jul 15, 2022	BUY	$230.71 - $256.74 $23,071 - $25,674	100 Added 80.0%	225 $55,000
Q4 2020 Jan 13, 2021	BUY	$216.38 - $257.67 $27,047 - $32,208	125 New	125 $29,000
Q1 2019 Apr 12, 2019	SELL	$180.87 - $203.88 $24,779 - $27,931	-137 Closed	0 $0
Q1 2018 Apr 10, 2018	SELL	$169.43 - $198.0 $2,710 - $3,168	-16 Reduced 10.46%	137 $23,000
Q3 2017 Oct 20, 2017	BUY	$167.29 - $191.0 $25,595 - $29,223	153	153 $29,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $155B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norway Savings Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norway Savings Bank with notifications on news.

Account

Norway Savings Bank Amgen Inc Transaction History